BVF GP HOLDINGS LLC
CIK 1803809 · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$385.77M
Companies
9
Total Filings
19
Lifetime Open-Market Net
$766.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | Director | 2,755,533 | $11.62 | $32.02M | $225.71M | 4 | 2026-06-23 |
| KYMR | Director | 294,632 | $106.16 | $31.28M | $154.35M | 3 | 2024-08-22 |
| MLTX | Director | 11,265,678 | $18.71 | $210.78M | $0 | 1 | 2023-06-12 |
| XOMAP | Director | 1,818,637 | $24.98 | $45.43M | $4.09M | 2 | 2023-05-19 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 2,969,742 | $2.65 | $7.87M | $218.59M | 1 | 2022-06-06 |
| Merus N.V. (MRUS) Delisted | 10%+ Owner | 3,803,152 | $90.00 | $342.28M | $99.89M | 3 | 2021-04-01 |
| IDYA | 1,642,186 | $36.16 | $59.38M | $8.54M | 2 | 2021-02-04 | |
| XOMA | 10%+ Owner | 171,336 | $40.17 | $6.88M | $54.99M | 2 | 2020-12-15 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | 10%+ Owner | 541,116 | $38.00 | $20.56M | $1.2K | 1 | 2020-09-24 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-02 | OLMA | Buy (P) | +7,396,750 | $69.46M | EDGAR |
| 2021-04-01 | Merus N.V. (MRUS) Delisted | Buy (P) | +3,000,000 | $59.25M | EDGAR |
| 2021-03-24 | Merus N.V. (MRUS) Delisted | Buy (P) | +795,000 | $18.09M | EDGAR |
| 2021-02-04 | IDYA | Sell (S) | −464,090 | -$8.35M | EDGAR |
| 2020-12-15 | XOMA | Buy (P) | +2,000,000 | $50.00M | EDGAR |
| 2020-09-24 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Buy (P) | +320 | $1.2K | EDGAR |
| 2020-09-08 | Merus N.V. (MRUS) Delisted | Buy (P) | +2,019,060 | $22.55M | EDGAR |
| 2020-08-14 | XOMA | Buy (P) | +270,220 | $4.99M | EDGAR |
| 2020-06-22 | IDYA | Buy (P) | +1,179,960 | $16.89M | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.